August 2008 became one of the key stages in the history of MOLISAN.
At the beginning of August 2008, I was staying with my family in Sachkhere, in the village of Nigvzara, as guests of close friends. We had come there with five children for an ordinary summer holiday and planned to return home soon.
On August 8, the war began.
Ordinary life changed within just a few hours. News of the fighting, conflicting information about the roads, constant phone calls, concern for our loved ones and complete uncertainty — no one knew what would happen next.
With five children, we were effectively cut off from home.
In that situation, of course, all our attention was focused on the children. We had to remain calm, follow the news, try to understand which roads were safe and when there might finally be an opportunity to return home.
But the body was responding to what was happening in its own way.
It was during those days, against the background of severe stress, that a trophic ulcer appeared on my leg.
For me, this became another problem — this time a very personal one. I understood that such wounds can remain unhealed for a long time, recur, gradually enlarge and eventually become a permanent part of a person's life.
I had no intention of accepting that.
After the war ended, the children and I returned home safely. But the problem that had not existed before returned home with me.
That was the beginning of a new line of work.
I began studying the available information about chronic wounds and the processes of tissue cleansing and repair, analysing the properties of different components and creating the first versions of a product for caring for my own wound.
There was no single moment when a finished formula suddenly appeared. Everything developed gradually.
Search. First trial. Observation of the wound. Adjustment of the composition. Another trial. And observation again.
My own wound became a case in which I could directly see the changes taking place and understand which direction to take next.
Gradually, a version of the composition emerged with which the condition of the wound began to change in a favourable direction. I continued using it while observing the dynamics and adjusting the product.
The wound began to clean, its condition improved, and then the defect gradually began to close.
This was the first result that gave me a reason to continue the work.
Eventually, my trophic ulcer healed completely before it had time to increase significantly in size.
Only a small pigmented spot remained in its place. It is still there today.
Many years have passed, but whenever I look at it, I remember August 2008 again.
Yet the healing of my own wound was not the end of this story, but its beginning.
A single personal case, however convincing it may seem to the person observing the result on himself, cannot be a sufficient basis for conclusions about what a product may be capable of.
So the work continued.
The composition was refined, and experience accumulated from its use for different skin injuries and long-standing wounds. Gradually, other people began using the product.
And other stories appeared.
We began receiving photographs showing wound progress, messages from patients and their relatives, and later letters from people who had been dealing with their problem for months and years. Some described wounds that had existed for many years and, in individual cases, for decades.
These observations gradually showed that the solution originally created for my own wound had proved useful far beyond a single personal case.
This is how the direction now presented as the following took shape:
MOLISAN — SKIN & WOUND CARE SOLUTION.
Its history did not begin with market research or a decision to launch yet another product.
It began in August 2008 — with war, severe stress and a small wound on my leg that I refused to accept as something I simply had to live with.
What followed happened in the same way as it would happen more than once later in the history of MOLISAN:
a real problem arose;
the problem forced a search for a solution;
the first results required further testing and refinement;
and a solution initially found for myself and my family gradually began helping other people.
Sometimes the beginning of a big story remains very small.
In my case, that reminder is still a small pigmented spot on my leg — the trace of that wound and of that August in 2008.
David Tomadze
Founder of MOLISAN